semaglutide
Commercial- Indications
- Obesity, Weight management
Company intelligence / Profile preview
ShedRx is a telehealth weight-loss clinic offering prescription medications such as semaglutide and tirzepatide for weight management. The company provides both injectable and lozenge formulations of these GLP‑1-based therapies. Clinical results referenced are consistent with published data on these agents—substantial weight loss in patients using GLP‑1 or dual GLP‑1/GIP agonists alongside lifestyle changes[2]. No proprietary clinical trial data from the company itself is available.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ShedRx.